KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Liabilities and Shareholders Equity (2016 - 2025)

Pfizer (PFE) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $208.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 2.27% to $208.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $414.2 billion, a 52.37% decrease, with the full-year FY2025 number at $208.2 billion, down 2.27% from a year prior.
  • Liabilities and Shareholders Equity was $208.2 billion for Q4 2025 at Pfizer, up from $206.0 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $227.0 billion in Q4 2023 to a low of $41.1 billion in Q4 2022.
  • A 5-year average of $173.9 billion and a median of $207.1 billion in 2025 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: tumbled 70.09% in 2022, then surged 422.64% in 2023.
  • Pfizer's Liabilities and Shareholders Equity stood at $181.5 billion in 2021, then crashed by 70.09% to $54.3 billion in 2022, then soared by 318.26% to $227.0 billion in 2023, then dropped by 6.17% to $213.0 billion in 2024, then decreased by 2.27% to $208.2 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Liabilities and Shareholders Equity are $208.2 billion (Q4 2025), $206.0 billion (Q2 2025), and $213.0 billion (Q4 2024).